Organisation
Connexin Signalling Research Group
Research Group
To elucidate the role of connexin and pannexin signalling in health and disease with focus on the liver (VUB team) and the nervous system (UGent team).
Projects
1 - 5 of 5
- H2020: Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessmentFrom1 May 2021 → TodayFunding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- H2020: CSA: TWINALT: Twinning towards excellence in alternative methods for toxicity assessmentFrom1 Sep 2020 → 31 Aug 2023Funding: H2020-EU.1.2.- EXCELLENT SCIENCE - Future and Emerging Technologies (FET)
- GEAR: Brussels Liver Research to Valorisation Alliance (B-Liver): Valorisation of VUB’s liver cell biology and toxicology expertise via a consortium focused on liver therapeutics, patient and consumer safety.From1 Jan 2020 → TodayFunding: IOF - technology concept exploration, IOF - mandates
- CONNECT-2-CLINIC: Connexin and pannexin peptidomimetics and nanobodies for the clinical treatment of liver disease.From1 Jan 2020 → 31 Dec 2021Funding: H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)
- Human stem cells-on-a-chip: a new 3D platform for drug-induced liver steatosisFrom1 Jan 2017 → 31 Dec 2020Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 167
- Opinion of the scientific committee on consumer safety (SCCS) - Final opinion on Polyaminopropyl Biguanide (PHMB) in cosmetic products - Submission III(2017)
Authors: Vera Rogiers
Pages: 328-329 - Assaying Cellular Viability Using the Neutral Red Uptake Assay(2017)Series: Methods in Molecular BiologyVolume: 1601
Authors: Tamara Vanhaecke, Vera Rogiers
Pages: 19-26Number of pages: 8 - Opinion of the Scientific Committee on Consumer Safety (SCCS)--The safety of the use of formaldehyde in nail hardeners(2015)
Authors: Ulrike Bernauer, Pieter-Jan Coenraads, Gisela H Degen, Maria Dusinska, Werner Lilienblum, Andreas Luch, Elsa Nielsen, Thomas Platzek, Suresh Rastogi, Christophe Rousselle, et al.
Pages: 658-659 - Adverse outcome pathways: hype or hope?(2014)
Authors: Mathieu Vinken, Maurice Whelan
Pages: 1-2 - Opinion of the Scientific Committee on Consumer Safety (SCCS) – Opinion on the safety of the use of -arbutin in cosmetic products(2015)
Authors: Ulrike Bernauer, Pieter-Jan Coenraads, Gisela Degen, Maria Dusinska, Werner Lilienblum, Andreas Luch, Elsa Nielsen, Thomas Platzek, Suresh Rastogi, Christophe Rousselle, et al.
Pages: 866-867 - Adverse outcome pathways as tools to assess drug-induced toxicity(2016)Series: Methods in Molecular BiologyVolume: 1425
Authors: Mathieu Vinken
Pages: 325-337 - HeMiBio: hepatic microfluidic bioreactor(2015)Volume: 5
Authors: Laurent Barbe, Philippe Collas, Christiane Dascher-Nadel, Silvia Generelli, Leo van Grunsven, Sofia Leite, Yaakov Nahmias, Pau Sancho-Bru, Catherine Verfaillie, Mathieu Vinken
Pages: 114-134 - COVID-19 and the liver: an adverse outcome pathway perspective(2021)
Authors: Mathieu Vinken
Pages: 152765 - Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity?(2014)
Authors: David Kirkland, Errol Zeiger, Frederica Madia, Nigel Gooderham, Peter Kasper, Anthony Lynch, Takeshi Morita, Gladys Quedraogo, Juan Manuel Parra Morte, Stefan Pfuhler, et al.
Pages: 55-68 - ESTIV2018: 20th anniversary of the International Congress on In Vitro Toxicology.(2019)
Authors: Mathieu Vinken, Laura Suter-Dick, Helena Kandarova
Pages: 293-295